Abstract
Annexin family proteins are a well-known multigene family of Ca2+-regulated phospholipid- and membrane-binding proteins. As one of the annexin family genes/proteins, accumulated researches have begun to reveal that annexin A3 (Anxa3) exhibits important roles in tumor development, metastasis and drug resistance. The summarized research evidences in recent years indicate Anxa3 might specifically functionalize either as a tumor suppressor or as a tumor promoter candidate for different cancers depending on the types of tumor cells and tissues. The up-regulation of Anxa3 was found to be correlated with enhanced drug resistance of ovarian cancer, to promote the developments of colorectal adenocarcinoma and pancreatic carcinoma, and to facilitate the metastases of lung adenocarcinoma and hepatocarcinoma; meanwhile, the decreased Anxa3 expressions was negatively correlated with the developments of prostatic carcinoma and renal carcinoma. It is conceivable that Anxa3 could be regarded as a target for therapeutic intervention and a biological indicator for tumor development, invasion and metastasis as well as for the prognosis of tumor patients.
Similar content being viewed by others
References
Perron B, Lewit-Bentley A, Geny B, Rosso-Marie F (1997) Can enzymatic activity, or otherwise, be inferred from structural studies of Annexin III? J Biol Chem 272:11321–11326
Moss SE, Morgan RO (2004) The annexins. Genome Biol 5:219
Mussunoor S, Murray GI (2008) The role of annexins in tumour development and progression. J Pathol 216:131–140
Gerke V, Moss SE (2002) Annexins: from structure to function. Physiol Rev 82:331–371
Rescher U, Gerke V (2004) Annexins-unique membrane binding proteins with diverse functions. Cell Sci 117:2631–2639
Hayes MJ, Moss SE (2004) Annexins and disease. Biochem Biophys Res Commun 322:1166–1170
Chan CM, Wong SC, Lam MY, Hui EP, Chan JK, Lo ES et al (2008) Proteomic comparison of nasopharyngeal cancer cell lines C666-1 and NP69 identifies down-regulation of annexin II and beta2-tubulin for nasopharyngeal carcinoma. Arch Pathol Lab Med 132:675–683
Yan XD, Pan LY (2006) Proteomic analysis of human ovarian cancer cell lines and their platinum-resistant clones. Chin J Obstet Gynecol 41:584–587
Yan XD, Jie Y, Hui YY, Mao N, Yang Y, Pan L (2010) Increased expression of annexin A3 is a mechanism of platinum resistance in ovarian cancer. Cancer Res 70:1616–1624
Liu YF, Xiao ZQ, Li MX, Li MY, Zhang PF, Li C et al (2009) Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma. J Pathol 217:54–64
Fitzpatrick JM, Schulman C, Zlotta AR, Schroder FH (2009) Prostate cancer: a serious disease suitable for prevention. BJU Int 103:864–870
Köllermann J, Schlomm T, Bang H, Schwall GP, von Eichel-Streiber C, Simon R et al (2008) Expression and prognostic relevance of annexin A3 in prostate cancer. Eur Urol 54:1314–1323
Nimi S, Harashima M, Masaru G, Hyuga M, Seki T, Ariga T et al (2005) Expression of annexin A3 in primary cultured parenchymal rat hepatocytes and inhibition of DNA synthesis by suppression of annexin A3 expression using RNA interference. Biol Pharm Bull 28:424–428
Harashima M, Nimi S, Koyanagl H, Hyuga M, Noma S, Seki T et al (2006) Change in annexin A3 expression by regulatory factors of hepatocyte growth in primary cultured rat hepatocytes. Biol Pharm Bull 29:1339–1343
Sun MZ, Liu SQ, Tang JW (2009) Proteomics investigation of mouse hepatocarcinoma cell lines with different lymph node metastasis capacities. Chem J Chin Univ 30:517–524
Sun MZ, Liu S, Tang J, Wang J, Gong X, Sun C et al (2009) Proteomics analysis of two mice hepatocarcinoma ascites syngeneic cell lines with high and low lymph node metastasis rates provide potential protein markers for tumor malignancy attributes to lymphatic metastasis. Proteomics 9:3285–3302
Liu S, Sun MZ, Tang J, Wang J, Sun M-Z, Greenaway FT (2008) High performance liquid chromatography/nano-electrospray ionization tandem mass spectrometry, two-dimensional difference in-gel electrophoresis and gene microarray identification of lymphatic metastasis-associated biomarker. Rapid Commun Mass Spectrom 22:3172–3178
Liang RC, Neo JC, Lo SL, Tan GS, Seow TK, Chung MC (2002) Proteome database of hepatocellular carcinoma. J Chromatogr B 771:303–328
Gupta K, Miller JD, Li JZ, Russell MW, Charbonneau C (2008) Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev 34:193–205
Bianchi C, Bombelli S, Raimondo F, Torsello B, Angeloni V, Ferrero S et al (2010) Primary cell cultures from human renal cortex and renal cell carcinoma evidence a differential expression of two spliced isoforms of annexin A3. Am J Pathol 176:1660–1670
Park JE, Lee DH, Lee JA, Park SG, Kim NS, Park BC et al (2005) Annexin A3 is a potential angiogenic mediator. Biochem Biophys Res Commun 337:1283–1287
Yip KT, Das PK, Suria D, Lim CR, Ng GH, Liew CC (2010) A case-controlled validation study of a blood based seven gene biomarker panel for colorectal cancer in Malaysia. J Exp Clin Cancer Res 29:128
Baine MJ, Chakraborty S, Smith LM, Mallya K, Sasson AR, Brand RE et al (2011) Transcriptional profiling of peripheral blood mononuclear cells in pancreatic cancer patients identifies novel genes with potential diagnostic utility. PLoS ONE 6:e17014
Sopkova J, Raguenes-Nicol C, Vincent M, Chevalier A, Lewit-Bentley A, Russo-Marie F et al (2002) Ca2+ and membrane binding to annexin 3 modulate the structure and dynamics of its N terminus and domain III. Protein Sci 11:1613–1625
Hofmann A, Raguenes-Nicol C, Favier-Perron B, Mesonero J, Huber R, Russo-Marie F et al (2000) The annexin A3 membrane interaction is modulated by an N-terminal tryptophan. Biochemistry 39:7712–7721
Acknowledgments
This research was supported by grants from National Natural Science Foundation of China (81050010; 81171957) and Key Laboratory of Department of Education of Liaoning (LS2010050). We thank Prof. Frederick Greenaway at Clark University, USA for reading the manuscript and editing the English of the manuscript.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Na Wu and Shuqing Liu contributed equally as the first author.
Rights and permissions
About this article
Cite this article
Wu, N., Liu, S., Guo, C. et al. The role of annexin A3 playing in cancers. Clin Transl Oncol 15, 106–110 (2013). https://doi.org/10.1007/s12094-012-0928-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-012-0928-6